Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference
call on Thursday, August 8, 2013, at 8:30 a.m. ET. During the call,
management will review the company's second quarter 2013 financial
results and provide an update on Infinity's business.
A live webcast of the conference call can be accessed in the
Investors/Media section of Infinity's website at www.infi.com.
To participate in the conference call, please dial 1-877-316-5293
(domestic) and 1-631-291-4526 (international) five minutes prior to
start time. The conference ID number is 23079300. An archived version of
the webcast will be available on Infinity's website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to
discovering, developing and delivering best-in-class medicines to people
with difficult-to-treat diseases. Infinity combines proven scientific
expertise with a passion for developing novel small molecule drugs that
target emerging disease pathways. Infinity’s programs focused on the
inhibition of phosphoinositide-3-kinase and heat shock protein 90 are
evidence of its innovative approach to drug discovery and development.
For more information on Infinity, please refer to the company’s website
at www.infi.com.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130801005040r1&sid=ntxv4&distro=nx)
Copyright Business Wire 2013